Nanosonics Limited (NAN) and GE Healthcare (GEHC), a division of The General Electric Company, announced a distribution agreement providing GEHC with exclusive distribution rights for Nanosonics’ Trophon® EPR ultrasound probe disinfector and its consumables in USA and Canada. The agreement also provides GE Healthcare non-exclusive OEM co-sales of the Trophon EPR with GEHC ultrasound consoles in other countries outside the USA and Canada.
“The proposed alliance with GE Healthcare represents Nanosonics’ accomplishment, on schedule, of its next major step toward the sale of Trophon EPR and its consumables in North America, the world’s largest market for ultrasound equipment,” said David Radford, CEO of Nanosonics. “Nanosonics’ 510(k) application to the FDA remains on track, with its previously anticipated timelines. Distribution in the US market will commence following FDA clearance of the Trophon EPR and its consumable.”
GEHC is the leading supplier of ultrasound equipment in USA and Canada, and has global market leadership in key obstetric/gynaecological applications. This alliance between GEHC and Nanosonics also provides for further product development opportunities to address the needs of GEHC’s customers worldwide. Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets. GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Headquartered in the United Kingdom, GE Healthcare is a $16 billion unit of General Electric Company. Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.